Synthetic N-pyridinyl(methyl)-indol-3-ylpropanamides as new potential immunosuppressive agents

European Journal of Medicinal Chemistry

Volumn 42, Issue 5, 2007, Pages 686-693

  Carbonnelle, Delphine ^a   Lardic, Morgane ^a   Dassonville, Alexandra ^a   Verron, Elise ^a   Petit, Jean Yves ^a   Duflos, Muriel ^a   Lang, François ^a  

^a UNIVERSITÉ DE NANTES   (France)

Author keywords

Immunosuppression; N Pyridinyl(methyl) indol 3 ylpropanamides; T lymphocytes

Indexed keywords

3 (5 CHLORO 1 METHYLINDOL 3 YL) PROPANOIC ACID; CYCLOSPORIN A; ETHYL 3 (5 CHLORO 1 METHYLINDOL 3 YL) PROP 2 ENOATE; ETHYL 3 (5 CHLORO 1 METHYLINDOL 3 YL) PROPANOATE; IMMUNOSUPPRESSIVE AGENT; N (4,6 DIMETHYLPYRIDIN 2 YL) 3 (1 BENZYLINDOL 3 YL) PROPANAMIDE; N (4,6 DIMETHYLPYRIDIN 2 YL) 3 [1 (4 CHLOROBENZYL) INDOL 3 YL]PROPANAMIDE; N (4,6 DIMETHYLPYRIDIN 2 YL) 3 [5 CHLORO 1 (4 CHLOROBENZYL)INDOL 3 YL]PROPANAMIDE; N (PYRIDIN 4 YL) 3 (1 BENZYLINDOL 3 YL) PROPANAMIDE; N (PYRIDIN 4 YL) 3 [1 (4 CHLOROBENZYL)INDOL 3 YL] PROPANAMIDE; N [(PYRIDIN 3 YL)METHYL] 3 (1 BENZYLINDOL 3 YL) PROPANAMIDE; N [(PYRIDIN 3 YL)METHYL] 3 (5 CHLORO 1 METHYLINDOL 3 YL)PROPANAMIDE; N PYRIDINYL(METHYL) INDOL 3 YLPROPANAMIDE DERIVATIVE; PROPIONAMIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG ACTIVITY; DRUG INHIBITION; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; NONHUMAN; T LYMPHOCYTE;

AMIDES; ANIMALS; CELL PROLIFERATION; FEMALE; HUMANS; HYPERSENSITIVITY, DELAYED; IMMUNOSUPPRESSIVE AGENTS; INDOLES; MICE; MICE, INBRED BALB C; PYRIDINES; T-LYMPHOCYTES;

EID: 34248373729     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2006.12.013     Document Type: Article

References (20)

1. Masri M.A. Mol. Immunol. 39 (2003) 1073-1077
2. Takemoto S.K., Terasaki P.I., Gjertson D.W., and Cecka J.M. N. Engl. J. Med. 343 (2000) 1078-1084
3. Yu X., Carpenter P., and Anasetti C. Lancet 357 (2001) 1959-1963
4. Margreiter R. Lancet 359 (2002) 741-746
5. Vanrenterghem Y., van Hooff J.P., Klinger M., Wlodarczyk Z., Squifflet J.P., Mourad G., Neuhaus P., Jurewicz A., Rostaing L., Charpentier B., Paczek L., Kreis H., Chang R., Paul L.C., Grinyo J.M., and Short C. Transplantation 78 (2004) 9-14
6. Boubenider S., Hiesse C., Goupy C., Kriaa F., Marchand S., and Charpentier B. J. Nephrol. 10 (1997) 136-145
7. Cacciarelli T.V., Green M., Jaffe R., Mazariegos G.V., Jain A., Fung J.J., and Reyes J. Transplantation 66 (1998) 1047-1052
8. Boots J.M., Christiaans M.H., and van Hooff J.P. Drugs 64 (2004) 2047-2073
9. Vial T., and Descotes J. Toxicology 185 (2003) 229-240
10. Hariharan S. Transplantation 75 (2003) 1610-1614
11. Libby P., and Pober J.S. Immunity 14 (2001) 387-397
12. Carbonnelle D., Ebstein F., Rabu C., Petit J.Y., Gregoire M., and Lang F. Eur. J. Immunol. 35 (2005) 546-556
13. Sabourin C., Robert J.M., Robert-Piessard S., Carbonnelle D., and Lang F. J. Enzyme Inhib. Med. Chem. 19 (2004) 459-465
14. Duflos M., Nourrisson M.R., Brelet J., Courant J., Le Baut G., Grimaud N., and Petit J.Y. Eur. J. Med. Chem. 36 (2001) 545-553
15. Breteche A., Duflos M., Dassonville A., Nourrisson M.R., Brelet J., Le Baut G., Grimaud N., and Petit J.Y. J. Enzyme Inhib. Med. Chem. 17 (2002) 415-424
16. Gallard A., Duflos M., Nourrisson M.R., Le Baut G., Grimaud N., and Petit J.Y. J. Enzyme Inhib. Med. Chem. 18 (2003) 201-208
17. Dassonville A., Breteche A., Evano J., Duflos M., Le Baut G., Grimaud N., and Petit J.Y. Bioorg. Med. Chem. Lett. 14 (2004) 5441-5444
18. Dantal J., Jacques Y., and Soulillou J.P. Transplantation 52 (1991) 110-115
19. Cher D.J., and Mosmann T.R. J. Immunol. 138 (1987) 3688-3694
20. Fouchard F., Menciu C., Duflos M., Le Baut G., Lambrey B., Mourgues M., and Perrissoud D. Arzneimittelforschung/Drugs Res. 49 I (1999) 96-105